GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $101,076,000 | +252590.0% | 466 | +33.1% | 0.00% | 0.0% |
| Q4 2020 | $40,000 | +17.6% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $34,000 | -24.4% | 350 | -4.6% | 0.00% | 0.0% |
| Q2 2020 | $45,000 | +40.6% | 367 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $32,000 | -69.5% | 367 | -63.8% | 0.00% | -66.7% |
| Q4 2019 | $105,000 | -21.1% | 1,013 | -12.9% | 0.00% | -25.0% |
| Q3 2019 | $133,000 | -27.3% | 1,163 | +9.4% | 0.00% | -42.9% |
| Q2 2019 | $183,000 | +45.2% | 1,063 | +45.4% | 0.01% | +16.7% |
| Q3 2018 | $126,000 | +16.7% | 731 | -5.2% | 0.01% | 0.0% |
| Q2 2018 | $108,000 | +50.0% | 771 | +20.5% | 0.01% | +20.0% |
| Q1 2018 | $72,000 | +7.5% | 640 | +24.3% | 0.01% | 0.0% |
| Q4 2017 | $67,000 | +28.8% | 515 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $52,000 | -1.9% | 515 | -3.9% | 0.01% | -16.7% |
| Q2 2017 | $53,000 | -10.2% | 536 | +8.1% | 0.01% | -33.3% |
| Q1 2017 | $59,000 | – | 496 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|